The standard treatment for the connective tissue disorder Marfan's syndrome (MFS) is β-blockade, aimed at reducing aortic wall stress. Angiotensin II type 1 and 2 receptors (AT 1 and AT 2 ...
According to the Marfan Foundation, Marfan syndrome is a genetic disorder that affects the body’s connective tissue by causing a defect or mutation in the gene that tells the body how to make a ...